For instance, in March 2023, the National Health Service (NHS) in England approved Wegovy, a weight-loss injection containing semaglutide
Intense Moisture Infusion: Our lavish formula deeply hydrates, leaving skin supple and smooth, without any greasy residue
This heightened risk might be associated with the exacerbation of chronic inflammatory states in patients undergoing prolonged combination therapy, potentially facilitating carcinogenic processes [8]
With recent FDA enforcement against misleading direct-to-consumer prescription drug advertising, telehealth and DTC platforms that advertise GLP-1 products will likely need more careful legal / regulatory oversight of their ad claims, especially around benefit claims and safety disclosures
Mindful practices like eating slowly and staying hydrated are key to allowing your body to properly adjust and for long-term success